# Dosing Study of Amino Acids in Seriously Ill Patients

> **NCT01923480** · PHASE4 · TERMINATED · sponsor: **Baxter Healthcare Corporation** · enrollment: 16 (actual)

## Conditions studied

- Parenteral Nutrition (No Primary Condition Studied)

## Interventions

- **DRUG:** 15% CLINISOL - Sulfite-free (Amino Acid) Injection
- **DRUG:** 15% CLINISOL - Sulfite-free (Amino Acid) Injection
- **DRUG:** 15% CLINISOL - Sulfite-free (Amino Acid) Injection

## Key facts

- **NCT ID:** NCT01923480
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923480, "Dosing Study of Amino Acids in Seriously Ill Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01923480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*